Find Dapansutrile manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 54863-37-5, 3-methanesulfonylpropanenitrile, 3-(methylsulfonyl)propanenitrile, Olt1177, Olt-1177, Dapansutrile [inn]
Molecular Formula
C4H7NO2S
Molecular Weight
133.17  g/mol
InChI Key
LQFRYKBDZNPJSW-UHFFFAOYSA-N
FDA UNII
2Z03364G96

Dapansutrile
Dapansutrile is an orally bioavailable inhibitor of the innate immune signaling sensor nucleotide-binding domain and leucine-rich repeat (NLR) family pyrin domain containing 3 (NLRP3; NACHT, LRR and PYD containing protein 3; NALP3), with potential immunomodulatory and anti-inflammatory activities. Upon oral administration, dapansutrile specifically binds to and inhibits NLRP3, the sensor component of the NLRP3 inflammasome, and prevents the formation of the NLRP3 inflammasome. This inhibits the production of the pro-inflammatory cytokines interleukin-1-beta (IL-1beta) and interleukin-18 (IL-18), which may prevent or reduce inflammation. NLRP3 plays an important role in immunity and inflammation.
1 2D Structure

Dapansutrile

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-methylsulfonylpropanenitrile
2.1.2 InChI
InChI=1S/C4H7NO2S/c1-8(6,7)4-2-3-5/h2,4H2,1H3
2.1.3 InChI Key
LQFRYKBDZNPJSW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CS(=O)(=O)CCC#N
2.2 Other Identifiers
2.2.1 UNII
2Z03364G96
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-(methylsulfonyl)propanenitrile

2. Olt-1177

3. Olt117

4. Olt1177

2.3.2 Depositor-Supplied Synonyms

1. 54863-37-5

2. 3-methanesulfonylpropanenitrile

3. 3-(methylsulfonyl)propanenitrile

4. Olt1177

5. Olt-1177

6. Dapansutrile [inn]

7. 3-methylsulfonylpropionitrile

8. 3-methylsulfonylpropanenitrile

9. 3-(methanesulfonyl)propanenitrile

10. Propanenitrile, 3-(methylsulfonyl)-

11. 2z03364g96

12. Dapansutrile(olt1177)

13. Dapansutrile (usan/inn)

14. Dapansutrile [usan:inn]

15. Dapansutrile [usan]

16. Dapansutrile (olt1177)

17. Dapansutrile [who-dd]

18. 3-methylsulphonyl-propionitrile

19. Schembl9934796

20. Chembl3989943

21. Gtpl10056

22. Dtxsid601336541

23. Unii-2z03364g96

24. Ex-a4519

25. Bdbm50505850

26. S8907

27. Zinc32005410

28. Akos010140086

29. Ac-36465

30. Bs-45330

31. Hy-17629

32. Cs-0016785

33. D5955

34. D10920

35. E74469

36. A936206

37. Q27255815

38. Z2719319073

2.4 Create Date
2007-02-08
3 Chemical and Physical Properties
Molecular Weight 133.17 g/mol
Molecular Formula C4H7NO2S
XLogP3-0.7
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass133.01974964 g/mol
Monoisotopic Mass133.01974964 g/mol
Topological Polar Surface Area66.3 Ų
Heavy Atom Count8
Formal Charge0
Complexity190
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Inflammatory Agents

Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)


4.2 Mechanism of Action

Dapansutrile specifically inhibits the NLRP3 inflammasome and subsequent activation of IL-1. It is currently being investigated against gout flares, joint pain and COVID-19.


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Looking for 54863-37-5 / Dapansutrile API manufacturers, exporters & distributors?

Dapansutrile manufacturers, exporters & distributors 1

88

PharmaCompass offers a list of Dapansutrile API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dapansutrile manufacturer or Dapansutrile supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dapansutrile manufacturer or Dapansutrile supplier.

PharmaCompass also assists you with knowing the Dapansutrile API Price utilized in the formulation of products. Dapansutrile API Price is not always fixed or binding as the Dapansutrile Price is obtained through a variety of data sources. The Dapansutrile Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Dapansutrile

Synonyms

54863-37-5, 3-methanesulfonylpropanenitrile, 3-(methylsulfonyl)propanenitrile, Olt1177, Olt-1177, Dapansutrile [inn]

Cas Number

54863-37-5

Unique Ingredient Identifier (UNII)

2Z03364G96

About Dapansutrile

Dapansutrile is an orally bioavailable inhibitor of the innate immune signaling sensor nucleotide-binding domain and leucine-rich repeat (NLR) family pyrin domain containing 3 (NLRP3; NACHT, LRR and PYD containing protein 3; NALP3), with potential immunomodulatory and anti-inflammatory activities. Upon oral administration, dapansutrile specifically binds to and inhibits NLRP3, the sensor component of the NLRP3 inflammasome, and prevents the formation of the NLRP3 inflammasome. This inhibits the production of the pro-inflammatory cytokines interleukin-1-beta (IL-1beta) and interleukin-18 (IL-18), which may prevent or reduce inflammation. NLRP3 plays an important role in immunity and inflammation.

Dapansutrile Manufacturers

A Dapansutrile manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dapansutrile, including repackagers and relabelers. The FDA regulates Dapansutrile manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dapansutrile API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Dapansutrile Suppliers

A Dapansutrile supplier is an individual or a company that provides Dapansutrile active pharmaceutical ingredient (API) or Dapansutrile finished formulations upon request. The Dapansutrile suppliers may include Dapansutrile API manufacturers, exporters, distributors and traders.

Dapansutrile GMP

Dapansutrile Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Dapansutrile GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dapansutrile GMP manufacturer or Dapansutrile GMP API supplier for your needs.

Dapansutrile CoA

A Dapansutrile CoA (Certificate of Analysis) is a formal document that attests to Dapansutrile's compliance with Dapansutrile specifications and serves as a tool for batch-level quality control.

Dapansutrile CoA mostly includes findings from lab analyses of a specific batch. For each Dapansutrile CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Dapansutrile may be tested according to a variety of international standards, such as European Pharmacopoeia (Dapansutrile EP), Dapansutrile JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dapansutrile USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty